Humira®

 
Active substance Adalimumab
Holder AbbVie sa/nv
Status closed
Indication Active moderate to severe Hidradenitis Suppurativa (HS) in adult patients with an inadequate response to conventional systemic HS therapy
Public documents Approbation
Information for the patient
Informed consent
Last update 01/09/2016
Last updated on 13/09/2024